Q2 2019 United Therapeutics Corp Earnings Call Transcript
Good morning, and welcome to the United Therapeutics Corporation Second Quarter 2019 Earnings Call. My name is Michelle, and I will be your conference operator today. (Operator Instructions)
I will now turn the conference over to Mr. James Edgemond, Chief Financial Officer of United Therapeutics.
Thank you, Michelle, and good morning, everyone. It is my pleasure to welcome you to the United Therapeutics Corporation's Second Quarter 2019 Earnings Call. Accompanying me on today's call are Dr. Martine Rothblatt, our Chairman and Chief Executive Officer; and Mr. Michael Benkowitz, our President and Chief Operating Officer. Remarks today will include forward-looking statements representing our expectations or beliefs regarding future events. These statements involve risks and uncertainties that may cause actual results to differ materially. Our latest SEC filings, including Form 10-K and 10-Q, contain additional information on these risks and uncertainties. We assume no obligation to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |